We know who they are
aspe.hhs.gov
Insulin Affordability and the Inflation Reduction Act: Medicare Beneficiary Savings by State and Demographics
Effective January 1, 2023, out-of-pocket costs for insulin are capped at $35 per monthly prescription among Medicare Part D enrollees under the Inflation Reduction Act (IRA). A similar cap takes effect in Medicare Part B on July 1, 2023. An estimated 1.5 million Medicare beneficiaries who use...
Last edited:
